whyrybrevant.com domain details, RYBREVANT® for EGFR+ mNSCLC | RYBREVANT® (amivantamab-vmjw)

home > domains > whyrybrevant.com

domain urls (10) domain links in (0) domain links out (5)

Description: The official patient website for RYBREVANT® (amivantamab-vmjw) for the treatment of mNSCLC with EGFR Exon 20 insertion mutations. See Full Prescribing & Safety Info.

Domain rank: 100000000

Indexed URLs from whyrybrevant.com website (10)

The links in column here only counts links from external domains.

found date
links in
url title
url
2023-01-06
0
Privacy Policy | Janssen United States
whyrybrevant.com/privacy-policy
2022-07-18
0
RYBREVANT® for EGFR+ mNSCLC | RYBREVANT® (amivantamab-vmjw)
whyrybrevant.com/#main-content
2022-07-18
0
RYBREVANT® for EGFR+ mNSCLC | RYBREVANT® (amivantamab-vmjw)
whyrybrevant.com/#ISI
2022-07-22
0
Paying for RYBREVANT® | RYBREVANT® (amivantamab-vmjw)
whyrybrevant.com/paying-for-rybrevant
2022-07-18
0
What is RYBREVANT® | RYBREVANT® (amivantamab-vmjw)
whyrybrevant.com/what-is-rybrevant
2022-07-18
0
About Your EGFR Exon 20 Mutation | RYBREVANT® (amivantamab-vmjw)
whyrybrevant.com/about-your-mutation
2022-07-18
0
RYBREVANT® for EGFR+ mNSCLC | RYBREVANT® (amivantamab-vmjw)
whyrybrevant.com
2022-07-18
0
Contact Us | RYBREVANT® (amivantamab-vmjw)
whyrybrevant.com/contact-us
2022-07-18
0
whyrybrevant.com/how-rybrevant-is-administered
2023-01-06
0
Legal Notice | Janssen United States
whyrybrevant.com/legal-notice

Plain text list